FDA reviewers plot case for randomized data on blood cancer PI3K inhibitors ahead of advisory meeting – Endpoints News

0
60
FDA reviewers plot case for randomized data on blood cancer PI3K inhibitors ahead of advisory meeting – Endpoints News


What is CMV? If you’re like most people, you don’t know. Moderna wants to change that, especially for women ages 16-40 because CMV, or cytomegalovirus, is the leading infectious cause of birth defects in the US.

Moderna — currently in a Phase III study of its proposed CMV vaccine — is running a social and digital campaign including mom influencers and partnerships with popular media aimed at the target audience. Its campaign home website, “Now I Know CMV” includes facts and figures about CMV along with outside resource links to the Centers for Disease Control and the American Academy of Pediatrics. It also includes a link to a pre-screening and sign-up website for Moderna’s clinical trial, with a modern stylized “We Vs. CMV” theme.

Endpoints News

Keep reading Endpoints with a free subscription

Unlock this story instantly and join 140,100+ biopharma pros reading Endpoints daily — and it’s free.




Source link